392 material Form 8-K filings that 341 companies we cover made with the SEC in July 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Tompkins Financial reported second-quarter 2024 diluted earnings per share of $1.10 and net income of $15.7 million, both down from the prior quarter but up sharply from the second quarter of 2023, which included a $7.1 million loss on securities sales. The company also declared a $0.61 per share dividend payable August 16, 2024.
Diluted EPS was $1.10, down 6.8% from the first quarter of 2024 and up 86.4% from $0.59 a year earlier.
Net income was $15.7 million, down 7.1% from the prior quarter and up 85.0% from $8.5 million in the second quarter of 2023.
Net interest margin was 2.73%, unchanged from the first quarter and down from 2.83% a year earlier.
Dividend of $0.61 per share is payable August 16, 2024 to shareholders of record on August 9, 2024.
Portland General Electric reported second-quarter 2024 GAAP net income of $72 million, or $0.69 per diluted share, up from $39 million, or $0.39, a year earlier, and total revenues of $758 million versus $648 million. The company reaffirmed its full-year 2024 adjusted earnings guidance of $2.98 to $3.18 per diluted share and set up a new at-the-market stock sale program of up to $400 million, which could add shares outstanding.
Q2 2024 GAAP net income of $72 million ($0.69 per diluted share) vs. $39 million ($0.39) in Q2 2023
Total revenues of $758 million vs. $648 million in Q2 2023; total operating expenses rose to $642 million from $567 million
2024 adjusted EPS guidance of $2.98 to $3.18 reaffirmed, not changed
New at-the-market common stock offering program registered July 26, 2024, for up to $400 million; agents receive commissions of up to 2% of gross sales price
Franklin Resources reported third-quarter fiscal 2024 results for the quarter ended June 30, 2024. Operating revenues rose 8% year over year to $2,122.9 million, but net income attributable to the company fell 24% to $174.0 million, or $0.32 per diluted share, from $227.5 million, or $0.44, a year earlier. Adjusted diluted earnings per share were $0.60, compared with $0.63 a year earlier, and the filing gives no guidance.
Operating revenues were $2,122.9 million, up 8% from $1,969.0 million a year earlier but down 1% from $2,152.8 million in the prior quarter.
Net income attributable to Franklin Resources was $174.0 million, down 24% year over year and up 40% from $124.2 million in the prior quarter.
Adjusted diluted earnings per share were $0.60, versus $0.63 a year earlier and $0.56 in the prior quarter.
Ending assets under management were $1,646.6 billion at June 30, 2024, and the company repurchased 4.3 million shares for $101.5 million during the quarter.
Saia reported second quarter 2024 results with revenue of $823.2 million, up 18.5%, and diluted earnings per share of $3.83, up from $3.42 a year earlier. Operating ratio worsened to 83.3% from 82.7%, and management said it expects net capital expenditures of about $1 billion in 2024.
Operating income was $137.6 million, a 14.4% increase from the second quarter of 2023.
Operating ratio was 83.3%, compared with 82.7% a year earlier.
Net capital expenditures were $681.3 million in the first six months of 2024, and the company expects about $1 billion for the full year.
Cash on hand was $11.2 million and total debt was $176.7 million at June 30, 2024.
First Hawaiian reported second-quarter 2024 net income of $61.9 million, or $0.48 per diluted share, up from $54.2 million, or $0.42, in the first quarter and down from $62.4 million, or $0.49, in the second quarter of 2023. Net interest income fell 1.0% from the prior quarter to $152.9 million, while noninterest expense dropped $6.7 million to $122.1 million, and total deposits declined $350.6 million to $20.3 billion. The company also declared a quarterly dividend of $0.26 per share and did not repurchase any shares in the quarter.
Net income $61.9 million, $0.48 per diluted share, versus $54.2 million, $0.42 in Q1 2024 and $62.4 million, $0.49 in Q2 2023
Net interest income $152.9 million, down $1.6 million from Q1 2024; net interest margin rose 1 basis point to 2.92%
Noninterest expense $122.1 million, down $6.7 million from Q1 2024; total deposits $20.3 billion, down $350.6 million from March 31, 2024
Quarterly dividend of $0.26 per share, payable August 30, 2024, to holders of record on August 19, 2024; no shares repurchased in the quarter
WisdomTree reported second-quarter 2024 results with record assets under management of $109.7 billion and operating revenues of $107.0 million, up 10.5% from the prior quarter. Diluted EPS was $0.13 ($0.16 as adjusted), and net income was $21.8 million, down from $22.1 million in the first quarter and $54.3 million a year earlier, when a $41.4 million gain on gold payments was recorded. The board also declared a $0.03 quarterly dividend.
Operating revenues of $107.0 million, up 10.5% from the first quarter of 2024 and 24.9% from the second quarter of 2023
Diluted EPS of $0.13 on a GAAP basis and $0.16 as adjusted; net income of $21.8 million versus $22.1 million in the first quarter
Quarterly cash dividend of $0.03 per share, payable August 21, 2024 to holders of record on August 7, 2024
Balchem reported second quarter 2024 results for the period ended June 30, 2024, with net sales of $234.1 million, up 1.2%, and GAAP net earnings of $32.1 million, up 6.5%. Adjusted EBITDA was a record $62.3 million, up 5.0%, but the Animal Nutrition and Health segment's sales and earnings from operations fell sharply, which partly offset growth in the other two segments.
GAAP diluted earnings per share were $0.98, compared with $0.93 a year earlier; adjusted earnings per share were $1.09, compared with $1.06.
Human Nutrition and Health sales rose 9.0% to $147.9 million, and Specialty Products sales rose 7.2% to $35.1 million.
Animal Nutrition and Health sales fell 19.2% to $49.6 million, and its earnings from operations fell 64.9% to $2.7 million.
Free cash flow was $38.4 million, and the company repaid $35.0 million on its revolving debt, bringing net debt to $202.8 million.
Sensient reported second-quarter 2024 revenue of $403.5 million, up 7.8%, but operating income fell 3.7% to $49.7 million and diluted EPS fell 9.9% to 73 cents. The company raised its local currency revenue and adjusted EBITDA growth outlook, but narrowed its GAAP diluted EPS guidance lower by 3 cents at both ends to $2.77 to $2.87.
Revenue rose 7.8% to $403.5 million from $374.3 million a year earlier; operating income fell 3.7% to $49.7 million.
Diluted EPS was 73 cents versus 81 cents a year earlier, including $1.8 million of Portfolio Optimization Plan costs in the quarter.
Local currency revenue and adjusted EBITDA growth outlook raised to mid-to-high single digits from mid-single digits.
GAAP diluted EPS guidance lowered to between $2.77 and $2.87 from between $2.80 and $2.90; the company also posted an updated investor presentation on July 26, 2024.
T. Rowe Price reported second-quarter 2024 results on July 26, 2024, with net revenues of $1.7 billion, up 7.6% from a year earlier, and diluted earnings per share of $2.11, up 2.4% from a year earlier. The firm also recorded net client outflows of $3.7 billion, and both revenue and GAAP earnings fell from the first quarter of 2024.
Net revenues were $1,733.3 million in Q2 2024, up 7.6% from Q2 2023 and down 1.0% from Q1 2024.
GAAP diluted EPS was $2.11 versus $2.06 a year earlier and $2.49 in Q1 2024; adjusted diluted EPS was $2.26.
Ending assets under management were $1.57 trillion at June 30, 2024, after net client outflows of $3.7 billion in the quarter.
The firm returned $396 million to stockholders through dividends and stock repurchases in the quarter.
Virtus Investment Partners reported results for the quarter ended June 30, 2024, in a press release furnished as Exhibit 99.1 to its July 26, 2024 Form 8-K. Revenue rose 5% year over year to $224.4 million, but GAAP diluted earnings per share fell 41% to $2.43, with net investment losses and other items weighing on results, while adjusted diluted EPS rose 20% to $6.53. Assets under management fell 3% to $173.6 billion, with net outflows of $2.6 billion, which matters to shareholders because it reflects the asset base that generates the company's fees.
Revenues of $224.4 million, up 5% from $213.5 million a year earlier and up 1% from $222.0 million in the first quarter of 2024.
GAAP diluted EPS of $2.43, down from $4.10 a year earlier; adjusted diluted EPS of $6.53, up from $5.43.
Net outflows of $2.6 billion and total sales of $6.1 billion; ending assets under management of $173.6 billion, down 3% from $179.3 billion at March 31, 2024.
The company repurchased 55,099 shares for $12.5 million and repaid $5.7 million of debt during the quarter.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.